Antitumor efficacy of a monoclonal antibody that inhibits the activity of cancer-associated carbonic anhydrase XII

Cancer Research

Volumn 73, Issue 21, 2013, Pages 6494-6503

  Gondi, Gabor ^a   Mysliwietz, Josef ^a   Hulikova, Alzbeta ^c   Jen, Jian Ping ^c   Swietach, Pawel ^c   Kremmer, Elisabeth ^a   Zeidler, Reinhard ^a,b  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONATE DEHYDRATASE INHIBITOR; CARBONATE DEHYDRATASE XII; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 6A10; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CATALYSIS; CELL MEMBRANE; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG CANCER; MOUSE; NONHUMAN; OVERALL SURVIVAL; PH; PRIORITY JOURNAL; SURVIVAL TIME; TUMOR SPHEROID; TUMOR XENOGRAFT;

ANIMALS; ANTIBODIES, MONOCLONAL; APOPTOSIS; BLOTTING, WESTERN; CARBONIC ANHYDRASE INHIBITORS; CARBONIC ANHYDRASES; CATALYSIS; CELL MEMBRANE; CELL PROLIFERATION; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; HYDROGEN-ION CONCENTRATION; IMMUNOPRECIPITATION; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASMS; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED;

EID: 84887132805     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-13-1110     Document Type: Article

References (40)

1. Wykoff CC, Beasley NJ, Watson PH, Turner KJ, Pastorek J, Sibtain A, et al. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res 2000;60: 7075-83.
2. Ivanov S, Liao SY, Ivanova A, Danilkovitch-Miagkova A, Tarasova N, Weirich G, et al. Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. Am J Pathol 2001;158: 905-19.
3. Barnett DH, Sheng S, Charn TH, Waheed A, Sly WS, Lin CY, et al. Estrogen receptor regulation of carbonic anhydrase XII through a distal enhancer in breast cancer. Cancer Res 2008;68: 3505-15.
4. Parkkila S, Parkkila AK, Saarnio J, Kivela J, Karttunen TJ, Kaunisto K, et al. Expression of the membrane-associated carbonic anhydrase isozyme XII in the human kidney and renal tumors. J Histochem Cytochem 2000;48: 1601-8.
5. Kivela AJ, Parkkila S, Saarnio J, Karttunen TJ, Kivela J, Parkkila AK, et al. Expression of transmembrane carbonic anhydrase isoenzymes IX and XII in normal human pancreas and pancreatic tumours. Histochem Cell Biol 2000;114: 197-204.
6. Kivela A, Parkkila S, Saarnio J, Karttunen TJ, Kivela J, Parkkila AK, et al. Expression of a novel transmembrane carbonic anhydrase isozyme XII in normal human gut and colorectal tumors. Am J Pathol 2000;156: 577-84.
7. Chien MH, Ying TH, Hsieh YH, Lin CH, Shih CH, Wei LH, et al. Tumorassociated carbonic anhydrase XII is linked to the growth of primary oral squamous cell carcinoma and its poor prognosis. Oral Oncol 2012;48: 417-23.
8. Proescholdt MA, Mayer C, Kubitza M, Schubert T, Liao SY, Stanbridge EJ, et al. Expression of hypoxia-inducible carbonic anhydrases in brain tumors. Neuro Oncol 2005;7: 465-75.
9. Ilie MI, Hofman V, Ortholan C, Ammadi RE, Bonnetaud C, Havet K, et al. Overexpression of carbonic anhydrase XII in tissues from resectable non-small cell lung cancers is a biomarker of good prognosis. Int J Cancer 2011;128: 1614-23.
10. Hynninen P, Vaskivuo L, Saarnio J, Haapasalo H, Kivela J, Pastorekova S, et al. Expression of transmembrane carbonic anhydrases IX and XII in ovarian tumours. Histopathology 2006;49: 594-602.
11. Hynninen P, Parkkila S, Huhtala H, Pastorekova S, Pastorek J, Waheed A, et al. Carbonic anhydrase isozymes II, IX, and XII in uterine tumors. APMIS 2012;120: 117-29.
12. Karhumaa P, Parkkila S, Tureci O, Waheed A, Grubb JH, Shah G, et al. Identification of carbonic anhydrase XII as the membrane isozyme expressed in the normal human endometrial epithelium. Mol Human Reprod 2000;6: 68-74.
13. Liao SY, Ivanov S, Ivanova A, Ghosh S, Cote MA, Keefe K, et al. Expression of cell surface transmembrane carbonic anhydrase genes CA9 and CA12 in the human eye: overexpression of CA12 (CAXII) in glaucoma. J Med Genet 2003;40: 257-61.
14. Oksala N, Levula M, Pelto-Huikko M, Kytomaki L, Soini JT, Salenius J, et al. Carbonic anhydrases II and XII are up-regulated in osteoclast-like cells in advanced human atherosclerotic plaques-Tampere Vascular Study. Ann Med 2010;42: 360-70.
15. Kobayashi M, Matsumoto T, Ryuge S, Yanagita K, Nagashio R, Kawakami Y, et al. CAXII Is a sero-diagnostic marker for lung cancer. PLoS ONE 2012;7:e33952.
16. Tafreshi NK, Bui MM, Bishop K, Lloyd MC, Enkemann SA, Lopez AS, et al. Noninvasive detection of breast cancer lymph node metastasis using carbonic anhydrases IX and XII targeted imaging probes. Clin Cancer Res 2012;18: 207-19.
17. Chiche J, Ilc K, Laferriere J, Trottier E, Dayan F, Mazure NM, et al. Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH. Cancer Res 2009;69: 358-68.
18. Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008;7: 1-14.
19. Swietach P, Vaughan-Jones RD, Harris AL. Regulation of tumor pH and the role of carbonic anhydrase 9. Cancer Metastasis Rev 2007;26: 299-310.
20. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 1989;49: 6449-65.
21. Swietach P, Patiar S, Supuran CT, Harris AL, Vaughan-Jones RD. The role of carbonic anhydrase 9 in regulating extracellular and intracellular ph in three-dimensional tumor cell growths. J Biol Chem 2009;284: 20299-310.
22. Swietach P, Wigfield S, Cobden P, Supuran CT, Harris AL, Vaughan- Jones RD. Tumor-associated carbonic anhydrase 9 spatially coordinates intracellular pH in three-dimensional multicellular growths. J Biol Chem 2008;283: 20473-83.
23. Hulikova A, Vaughan-Jones RD, Swietach P. Dual role of CO2/HCO3(-) buffer in the regulation of intracellular pH of three-dimensional tumor growths. J Biol Chem 2011;286: 13815-26.
24. Morgan PE, Pastorekova S, Stuart-Tilley AK, Alper SL, Casey JR. Interactions of transmembrane carbonic anhydrase, CAIX, with bicarbonate transporters. Am J Physiol Cell Physiol 2007;293: C738-48.
25. Gillies RJ, Verduzco D, Gatenby RA. Evolutionary dynamics of carcinogenesis and why targeted therapy does not work. Nat Rev Cancer 2012;12: 487-93.
26. Estrella V, Chen T, Lloyd M, Wojtkowiak J, Cornnell HH, Ibrahim- Hashim A, et al. Acidity generated by the tumor microenvironment drives local invasion. Cancer Res 2013;73: 1524-35.
27. Gatenby RA, Gawlinski ET, Gmitro AF, Kaylor B, Gillies RJ. Acidmediated tumor invasion: a multidisciplinary study. Cancer Res 2006; 66: 5216-23.
28. McIntyre A, Patiar S,Wigfield S, Li JL, Ledaki I, Turley H, et al. Carbonic anhydrase IX promotes tumor growth and necrosis in vivo and inhibition enhances anti-VEGF therapy. Clin Cancer Res 2012;18: 3100-11.
29. Hsieh MJ, Chen KS, Chiou HL, Hsieh YS. Carbonic anhydrase XII promotes invasion and migration ability ofMDA-MB-231 breast cancer cells through the p38 MAPK signaling pathway. Eur J Cell Biol 2010; 89: 598-606.
30. Dubois L, Peeters S, Lieuwes NG, Geusens N, Thiry A, Wigfield S, et al. Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiation. Radiother Oncol 2011;99: 424-31.
31. Battke C, Kremmer E, Mysliwietz J, Gondi G, Dumitru C, Brandau S, et al. Generation and characterization of the first inhibitory antibody targeting tumour-associated carbonic anhydrase XII. Cancer Immunol Immunother 2011;60: 649-58.
32. Battke C, Ruiss R, Welsch U, Wimberger P, Lang S, Jochum S, et al. Tumour exosomes inhibit binding of tumour-reactive antibodies to tumour cells and reduce ADCC. Cancer Immunol Immunother 2011;60: 639-48.
33. Terziyska N, Castro Alves C, Groiss V, Schneider K, Farkasova K, Ogris M, et al. In vivo imaging enables high resolution preclinical trials on patients' leukemia cells growing inmice. PLoS ONE 2012;7: e52798.
34. Murri-Plesko MT, Hulikova A, Oosterwijk E, Scott AM, Zortea A, Harris AL, et al. Antibody inhibiting enzymatic activity of tumourassociated carbonic anhydrase isoform IX. Eur J Pharmacol 2011;657: 173-83.
35. Ulmasov B, Waheed A, Shah G, Grubb J, Sly W, Tu C, et al. Purification and kinetic analysis of recombinant CA XII, a membrane carbonic anhydrase overexpressed in certain cancers. Proc Natl Acad Sci U S A 2000;97: 14212-7.
36. Cory A, Owen T, Barltrop J, Cory J. Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun 1991;3: 207-12.
37. Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, Hioki K, et al. NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood 2002;100: 3175-82.
38. Schulze A, Harris A. How cancer metabolism is tuned for proliferation and vulnerable to disruption. Nature 2012;491: 364-73.
39. Leppilampi M, Saarnio J, Karttunen T, Kivela J, Pastorekova S, Pastorek J, et al. Carbonic anhydrase isozymes IX and XII in gastric tumors. World J Gastroenterol 2003;9: 1398-403.
40. Wykoff C, Beasley N, Watson P, Campo L, Chia S, English R, et al. Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast. Am J Pathol 2001;158: 1011-9.